G. Albadrani

A GPT-Driven De Novo Discovery of SIRT2 Inhibitors Against Breast Cancer

The findings demonstrate the potential of combining generative AI with high-throughput computational screening as an efficient, reliable, and scalable approach to identify inhibitors for breast cancer targets, although these inhibitors need to be tested in the lab to validate their biological activity and potential for...